BLE.F - bluebird bio, Inc.
Frankfurt - Frankfurt Delayed price. Currency in EUR
As of 05:13PM CEST. Market open.
Stock chart is not supported by your current browser
| Previous close | 15.90 |
| Open | 15.85 |
| Bid | 0.00 x 12000 |
| Ask | 0.00 x 12000 |
| Day's range | 15.85 - 15.90 |
| 52-week range | 15.31 - 49.99 |
| Volume | |
| Avg. volume | 103 |
| Market cap | 1.075B |
| Beta (5Y monthly) | 0.93 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Yahoo Finance Video
Bluebird Bio stock falls after FDA approves gene therapy
Yahoo Finance's Julie Hyman discusses the reversal in Bluebird Bio shares after the FDA approved its second gene therapy.
- Yahoo Finance
Stock market today: 4 tickers trending on Yahoo Finance
Stock futures are lower as investors await this week's Federal Reserve monetary policy meeting.
- Yahoo Finance Video
Bluebird stock pops after FDA approves its gene therapy drug
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss how Bluebird stock is trading after the FDA approved its gene therapy treatment.
- Simply Wall St.
What Kind Of Shareholders Hold The Majority In bluebird bio, Inc.'s (NASDAQ:BLUE) Shares?
If you want to know who really controls bluebird bio, Inc. ( NASDAQ:BLUE ), then you'll have to look at the makeup of...
